EMERALD (Emergency Medicine Cardiovascular Risk Assessment for Lipid Disorders)
Condition: Lipid Disorder Intervention: Drug: moderate- or high-intensity statin/ rosuvastatin Sponsor: Wake Forest University Health Sciences Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Cardiology | Cardiovascular | Cholesterol | Crestor | Emergency Medicine | Heart | Research | Rosuvastatin | Statin Therapy